← All trials
NCT00679055
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2007
- Primary completion
- Aug 26, 2008
- Completion date
- Aug 26, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 14
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- MerckLead sponsor
- MerckStudy director
- Foxhollow TechnologiesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.